Insiders · CLDX

CLDX insider transactions

Celldex Therapeutics Inc. (CLDX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CLDX

• 153d
  SVP AND CFO Martin Samuel Bates exercised 4,817 shares at a strike of $10.38, increasing direct ownership by 17% to 32,942 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 173d
  SR. VP & CBO Pepin Ronald exercised 19,333 shares at a strike of $5.47, increasing direct ownership by 2,530% to 20,097 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 182d
  SVP & GENERAL COUNSEL Jimenez Freddy A. sold $121,210 worth of shares (4,166 units at $29.09), decreasing direct ownership by 12% to 30,796 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 203d
  Former Officer Wright Richard M. sold $1,183,177 worth of shares (49,298 units at $24.00) and exercised 49,298 shares at a strike of $14.06 (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 208d
  SEC Form 4 filed by SVP & Chief Commercial Officer Lawver Teri L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 208d
  SEC Form 3 filed by new insider Lawver Teri L

  3 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 297d
  SVP & GENERAL COUNSEL Jimenez Freddy A. sold $19,096 worth of shares (771 units at $24.77), decreasing direct ownership by 2% to 34,962 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SVP OF CORP AFFAIRS & ADMIN. Cavanaugh Sarah

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SR. VP & CPDO Crowley Elizabeth

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SVP OF REGULATORY AFFAIRS Heath-Chiozzi Margo

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SVP & GENERAL COUNSEL Jimenez Freddy A.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SVP AND CFO Martin Samuel Bates

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SR. VP & CBO Pepin Ronald

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by SVP, CHIEF MEDICAL OFFICER Young Diane C.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by EXECUTIVE VP & CSO Keler Tibor

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by PRESIDENT & CEO Marucci Anthony S

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Torres Denice

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Jain Rita

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Neil Garry Arthur

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Penner Harry Jr

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Conrad Herbert J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Marino James J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Brownlie Keith L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 364d
  SEC Form 4 filed by Director Cohen Cheryl

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 367d
  SEC Form 3 filed by new insider Torres Denice

  3 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 565d
  Director Marino James J gifted 10,500 shares, decreasing direct ownership by 83% to 2,204 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 573d
  PRESIDENT & CEO Marucci Anthony S bought $308,430 worth of shares (11,500 units at $26.82), increasing direct ownership by 40% to 40,284 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 720d
  SVP AND CFO Martin Samuel Bates exercised 20,169 shares at a strike of $10.16 and sold $608,315 worth of shares (17,172 units at $35.42), increasing direct ownership by 12% to 28,125 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 720d
  SR. VP & CPDO Crowley Elizabeth exercised 30,000 shares at a strike of $10.38 and sold $1,045,962 worth of shares (30,000 units at $34.87) (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SVP & GENERAL COUNSEL Jimenez Freddy A.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SVP, CHIEF MEDICAL OFFICER Young Diane C.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SVP OF REGULATORY AFFAIRS Heath-Chiozzi Margo

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SVP OF CORP AFFAIRS & ADMIN. Cavanaugh Sarah

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SR. VP & CPDO Crowley Elizabeth

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SR. VP & CCO Wright Richard M.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SR. VP & CBO Pepin Ronald

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by SVP AND CFO Martin Samuel Bates

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by EXECUTIVE VP & CSO Keler Tibor

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by PRESIDENT & CEO Marucci Anthony S

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Jain Rita

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Neil Garry Arthur

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Cohen Cheryl

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Brownlie Keith L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Marino James J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Conrad Herbert J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Shoos Karen L.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 721d
  SEC Form 4 filed by Director Penner Harry Jr

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 725d
  SVP, CHIEF MEDICAL OFFICER Young Diane C. exercised 15,000 shares at a strike of $2.71, increasing direct ownership by 709% to 17,115 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 727d
  SR. VP & CPDO Crowley Elizabeth exercised 15,000 shares at a strike of $9.70 and sold $525,873 worth of shares (15,000 units at $35.06) (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 727d
  SVP, CHIEF MEDICAL OFFICER Young Diane C. sold $1,586,844 worth of shares (45,000 units at $35.26), decreasing direct ownership by 96% to 2,115 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 731d
  Jimenez Freddy A. exercised 9,540 shares at a strike of $10.38, increasing direct ownership by 37% to 35,464 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 733d
  Heath-Chiozzi Margo sold $1,964,088 worth of shares (58,369 units at $33.65) and exercised 64,658 shares at a strike of $10.25, increasing direct ownership by 89% to 13,383 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 733d
  Wright Richard M. exercised 67,469 shares at a strike of $18.79 and sold $1,579,353 worth of shares (46,844 units at $33.72), increasing direct ownership by 9,916% to 20,833 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 733d
  Jimenez Freddy A. sold $269,002 worth of shares (8,006 units at $33.60) and exercised 8,006 shares at a strike of $10.38 (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 735d
  Heath-Chiozzi Margo exercised 33,719 shares at a strike of $3.75 and sold $1,319,156 worth of shares (38,719 units at $34.07), decreasing direct ownership by 41% to 7,094 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 735d
  Martin Samuel Bates exercised 25,000 shares at a strike of $10.38 and sold $1,191,774 worth of shares (35,000 units at $34.05), decreasing direct ownership by 28% to 25,128 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 735d
  Cavanaugh Sarah exercised 20,853 shares at a strike of $5.80 and sold $703,334 worth of shares (20,853 units at $33.73) (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 735d
  Crowley Elizabeth exercised 42,945 shares at a strike of $4.01 and sold $1,298,384 worth of shares (38,597 units at $33.64), increasing direct ownership by 92% to 9,074 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 844d
  Jimenez Freddy A. exercised 24,166 shares at a strike of $3.86, increasing direct ownership by 1,375% to 25,924 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 886d
  Martin Samuel Bates exercised 10,750 shares at a strike of $2.78, increasing direct ownership by 44% to 35,128 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)